CDNA Current Ratio
Retrieved:
Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.
CDNA current ratio history
Current ratio (current assets / current liabilities). The available annual fiscal periods series contains 14 observations from Dec 31, 2012 to Dec 31, 2025.
| Period ending | Current Ratio |
|---|---|
| 2.8618× | |
| 3.9368× | |
| 4.0183× | |
| 5.105× | |
| 5.6061× | |
| 3.9455× | |
| 2.0651× | |
| 4.1588× | |
| 0.6239× | |
| 0.6532× | |
| 3.3848× | |
| 3.6233× | |
| 1.0761× | |
| 1.1816× |
Compare current ratio
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) current ratio
- Bridgebio Pharma Inc (BBIO) current ratio
- Brightspring Health Services Inc (BTSG) current ratio
- Madrigal Pharmaceuticals Inc (MDGL) current ratio
- Ensign Group Inc (ENSG) current ratio
- Glaukos Corp (GKOS) current ratio
- Vaxcyte Inc (PCVX) current ratio
- Krystal Biotech Inc (KRYS) current ratio
Compare all covered stocks by current ratio →
All CDNA financial metrics · CDNA stock overview · How to interpret financial metrics